Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GLTSCR1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RGS14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BPIFB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERPINB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
EP400NL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMAD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCEAL7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANGEL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDH8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HEMGN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGLV1-44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on